A detailed history of Legacy Financial Advisors, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Legacy Financial Advisors, Inc. holds 894 shares of REGN stock, worth $638,736. This represents 0.18% of its overall portfolio holdings.

Number of Shares
894
Previous 878 1.82%
Holding current value
$638,736
Previous $922,000 1.84%
% of portfolio
0.18%
Previous 0.18%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1024.09 - $1201.76 $16,385 - $19,228
16 Added 1.82%
894 $939,000
Q2 2024

Aug 13, 2024

BUY
$883.2 - $1071.19 $60,940 - $73,912
69 Added 8.53%
878 $922,000
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $54,161 - $59,601
60 Added 8.01%
809 $778,000
Q4 2023

Feb 06, 2024

BUY
$775.18 - $881.7 $62,789 - $71,417
81 Added 12.13%
749 $657,000
Q3 2023

Nov 13, 2023

BUY
$692.45 - $844.37 $115,639 - $141,009
167 Added 33.33%
668 $549,000
Q2 2023

Aug 08, 2023

BUY
$700.03 - $830.35 $32,201 - $38,196
46 Added 10.11%
501 $359,000
Q1 2023

May 03, 2023

BUY
$680.49 - $826.97 $28,580 - $34,732
42 Added 10.17%
455 $373,000
Q4 2022

Feb 06, 2023

BUY
$705.89 - $766.39 $5,647 - $6,131
8 Added 1.98%
413 $297,000
Q3 2022

Nov 09, 2022

SELL
$573.97 - $724.32 $6,313 - $7,967
-11 Reduced 2.64%
405 $279,000
Q2 2022

Aug 08, 2022

BUY
$548.35 - $738.84 $1,096 - $1,477
2 Added 0.48%
416 $246,000
Q1 2022

May 04, 2022

BUY
$595.12 - $698.43 $44,038 - $51,683
74 Added 21.76%
414 $289,000
Q4 2021

Feb 04, 2022

BUY
$543.48 - $670.97 $184,783 - $228,129
340 New
340 $215,000
Q2 2019

Aug 07, 2019

SELL
$299.6 - $414.82 $4,494 - $6,222
-15 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$372.08 - $439.57 $3,720 - $4,395
10 Added 200.0%
15 $6,000
Q4 2018

Jan 16, 2019

SELL
$335.82 - $403.04 $3,022 - $3,627
-9 Reduced 64.29%
5 $2,000
Q2 2018

Jul 17, 2018

BUY
$284.6 - $344.99 $2,276 - $2,759
8 Added 133.33%
14 $5,000
Q4 2017

Feb 09, 2018

BUY
$358.63 - $469.95 $2,151 - $2,819
6
6 $2,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Legacy Financial Advisors, Inc. Portfolio

Follow Legacy Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.